Colistin is the last resort antimicrobial agent to treat infections caused by most Gram-negative bacteria commonly seen in clinical settings, including Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa1,2. Bacterial strains that have acquired resistance to colistin ha...
Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 2006; 64: 7–15. Article CAS Google Scholar Cordery RJ, Roberts CH, Cooper SJ, Bellinghan G, Shetty N . Evaluation of risk factors...
In addition, we found a novel ST type of Escherichia coli (ST13667) and a newly discovered point mutation (K127E) in the MexZ gene of Pseudomonas aeruginosa. WGS plays a crucial role in AMR control, prevention strategies, as well as multifaceted intervention strategies. Keywords: genome ...
Particularly concerning in healthcare settings are the ESKAPE bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species) that frequently carry resistance mechanisms, allowing them to “escape” the biocidal effects of ...
Sci. 2017, 4, 57 20 of 24 bacteria included Acinetobacter baumannii, Pseudomonas oryzihabitans, Ochrobactrum anthropic and Bordetella/Alcaligenes/Moraxella spp. (data not shown). All 37 E. coli isolates were sensitive to gentamicin, whereas 97% and 94.5% were sensitive to ciprofloxacin and ...
Phenotypic characterization of multidrug-resistant Pseudomonas aeruginosa strains isolated from pediatric patients associated to biofilm formation. Microbiol. Res. 2015, 172, 68–78. [Google Scholar] [CrossRef] Clermont, O.; Bonacorsi, S.; Bingen, E. Rapid and simple determination of the Escherichia...
(CR-GNB) bloodstream infection (BSI) in intensive care units (ICUs), the identification of specific risk factors and the development of a predictive model allowing for the early identification of patients at risk for CR-Klebsiella pneumoniae, Acinetobacter baumannii or Pseudomonas aeruginosa are ...
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum beta-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). Clin. Infect. Dis. 2022, 75, ...
Both OligoG–colistin conjugates caused significant disruption of Pseudomonas aeruginosa biofilm formation and induced bacterial death (confocal laser scanning microscopy). When conjugates were tested in an in vitro "time-to-kill" (TTK) model using Acinetobacter baumannii, only ester-linked conjugates ...
It should be noted that these drugs do not cover Pseudomonas aeruginosa and Proteae (Proteus, Morganella, Providencia); therefore, they should not be used in mixed infections where these pathogens are suspected. The clinical efficacy of some novel quinolones (avarofloxacin, finafloxacin, zabor...